Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea

Vox Sanguinis

Volumn 108, Issue 1, 2015, Pages 27-36

  Maslanka K ^a   Uhrynowska, M ^a   Lopacz P ^a   Wrobel A ^a   Smolenska Sym G ^a   Guz, K ^a   Lachert, E ^a   Ostas, A ^a   Brojer, E ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Cytokines; Leucocyte antibodies; Lysophospholipids; Microparticles; Pulmonary post transfusion reactions

Indexed keywords

CD40 LIGAND; CYTOKINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ANTIBODY; LYSOPHOSPHOLIPID; TUMOR NECROSIS FACTOR; ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD COMPONENT; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; ERYTHROCYTE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; POST TRANSFUSION REACTIONS WITH DYSPNEA; PROTEIN DETERMINATION; THROMBOCYTE; TRANSFUSION RELATED ACUTE LUNG INJURY; ACUTE LUNG INJURY; ADULT; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; FEMALE; MALE; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; THROMBOCYTE TRANSFUSION; TRANSFUSION REACTION;

ACUTE LUNG INJURY; ADULT; ANTIBODIES; CELL-DERIVED MICROPARTICLES; DYSPNEA; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; PLATELET TRANSFUSION; TRANSFUSION REACTION;

EID: 84919596687     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12190     Document Type: Article

References (63)

1. Bux J, Sachs UJ: Pulmonary transfusion reactions. Transf Med Hemother 2008; 35:337-345
2. Bux J: Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang 2011; 100:123-128
3. Skeate RC, Eastlund T: Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol 2007; 14:682-687
4. Popovsky MA: Pulmonary consequences of transfusion: TRALI and TACO. Tranfus Apher Sci 2006; 34:243-244
5. Barnard RD: Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951; 51:2399-2402
6. Popovsky MA, Abel MD, Moore SB: Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983; 128:185-189
7. Popovsky MA, Moore SB: Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25:573-577
8. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2011. Available at:http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm302847.htm (Last accessed 10 April 2013)
9. Popovsky MA: The Emily Cooley Lecture 2009. To breathe or not breathe - that is the question. Transfusion 2010; 50:2057-2067
10. Vlaar APJ, Juffermans NP: Transfusion-related acute lung injury: a clinical review. Lancet 2013; 382:984-994
11. Kopko PM, Marshall CS, MacKenzie MR, et al.: Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002; 287:1968-1971
12. Maślanka K, Michur H, Z˙upańska B, et al.: Leukocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang 2007; 92:247-249
13. Z˙upańska B, Uhrynowska M, Michur H, et al.: Transfusion-related acute lung injury and leukocyte-reacting antibodies. Vox Sang 2007; 93:70-77
14. Reil A, Keller-Stanislawski B, Gunay S, et al.: Specificities of leukocyte alloantibodies in transfusion-related acute lung injury and results of leukocyte antibody screening of blood donors. Vox Sang 2008; 95:313-317
15. Santoso S, Sachs UJ: New insights in mechanisms of transfusion-related acute lung injury. Vox Sang 2012; 7:124-128
16. Vlaar APJ, Kuipers MT, Hofstra JJ, et al.: Mechanical ventilation and the titer of antibodies as risk factors for the development of transfusion-related lung injury. Crit Care Res Pract vol. 2012, Article ID 720950, 7 pages, 2012. doi:10.1155/2012/720950
17. Van Buren NL, Stroncek DF, Clay ME, et al.: Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990; 30:42-45
18. Silliman CC, Clay KL, Thurman GW, et al.: Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124:684-694
19. Silliman CC, Voelkel NF, Allard JD, et al.: Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998; 101:1458-1467
20. Silliman CC, Bjornsen AJ, Wyman TH, et al.: Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003; 43:633-640
21. Silliman CC: The two-event model of transfusion-related acute lung injury. Crit Care Med 2006; 34(5 Suppl):S124-S131
22. Toy P, Gajic O, Bacchetti P, et al.: Transfusion-related acute lung injury: incidence and risk factors. Blood 2012; 119:1757-1767
23. Gilliss BM, Looney MR: Experimental models of transfusion-related lung injury (TRALI). Tranfus Med Rev 2011; 25:1-11
24. Silliman CC, Moore EE, Kelher MR, et al.: Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011; 51:2549-2554
25. Khan SY, Kelher MR, Heal JM, et al.: Soluble CD40 ligand accumalates in stored blood components, prime neutrophils through CD40 and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108:2455-2462
26. Maślanka K, Łopacz P, Wróbel A, et al.: Evaluation of the level of IL-1BETA, IL-6, IL-8, TNF-ALFA and sCD40L cytokines in stored erythrocyte and platelet concentrates. Vox Sang 2011; 101:159-160
27. Jy W, Ricci M, Shariatmadar S, et al.: Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion 2011; 51:886-893
28. Maślanka K, Michur H, Wróbel A, et al.: Microparticles in stored red blood cells and platelet concentrates. Vox Sang 2010; 99(Suppl. 2):30
29. Vlaar APJ: Transfusion-related acute lung injury: current understanding and preventive strategies. Transfus Clin Biol 2012; 19:117-124
30. Sayah DM, Looney MR, Toy P: Transfusion reaction, newer concepts on the pathophysiology, incidence, treatment and prevention of transfusion-related acute lung injury. Crit Care Clin 2012; 28:363-372
31. Silliman CC, Fung YL, Ball JB, et al.: Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev 2009; 23:245-255
32. Fung YI, Fraser JF, Wood P, et al.: The systematic inflammatory response syndrome induces functional changes and relative hypo-responsiveness in neutrophils. J Crit Care 2008; 23:542-549
33. Grommes J, Soehnlein O: Contribution of neutrophils to acute lung injury. Mol Med 2011; 17:293-307
34. Maślanka K, Smoleńska-Sym G, Michur H, et al.: Lysophosphatidylcholines: bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp (Warsz) 2012; 60:55-60
35. Vlaar AP, Kulik W, Nieuwland R, et al.: Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent. Transfusion 2011; 51:2358-2366
36. Sachs UJ, Weissmann N, Wasel W, et al.: Supernatants from stored leukodepleted packed red blood cells do not regularly exhibit changes in their lysophosphatidylcholine composition and do not cause TRALI in an ex vivo rat lung model. Vox Sang 2010; 99(Suppl. 1):456
37. Tuinman PR, Gerards MC, Jongsma G, et al.: Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury. Clin Exp Immunol 2011; 168:278-284
38. Łetowska M: Medyczne zasady pobierania krwi, oddzielania jej skladników i wydawania, 2nd edn. Warsaw, Institute of Hematology and Transfusion Medicine, 2011
39. Kleinman S, Caulfifield T, Chan P, et al.: Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44:1774-1789
40. Working Party on Haemovigilance: Proposed standard definitions for surveillance of non infectious adverse transfusion reactions. Available at: http://www.ihn-org.com/wp-content/uploads/2011/06/ISBT-definitions-for-non-infectious-transfusion-reactions.pdf
41. Lalezari P, Jiang A, Lee SA: Microagglutination technique for the detection of leukocyte agglutinins; in: Ray JG (ed.): NIAJD Manual of Tissue Techniques. Rockville, National Institute of Health publication, 1979:20-22
42. Verheugt FW, dem Borne AEG, Decary F, et al.: The detection of granulocyte alloantibodies with an inderict immunofluorescence test. Br J Haematol 1977; 36:533-544
43. Bux J, Kolber B, Kiefel V, et al.: Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immunization of granulocyte antigens. Transfus Med 1997; 3:157-162
44. Bux J, Stein EL, Santoso S, et al.: HNA gene frequencies in the German population, determined by polymerase chain reaction with sequence-specific primers. Transfusion 1995; 35:54-57
45. Bux J, Stein EL, Bierling P, et al.: Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood 1997; 89:1027-1034
46. Nielsen KR, Koelbaek MD, Varming K, et al.: Frequencies of HNA-1, HNA-3, HNA-4 and HNA-5 in the Danish and Zambian populations determined using a novel TaqMan real time polymerase chain reaction method. Tissue Antigens 2012; 80:249-253
47. Weerheim AM, Kolb AM, Sturk A, et al.: Phospholipid composition of cell-derived microparticles determined by one-dimensional performance thin-layer chromatography. Anal Biochem 2002; 302:191-198
48. Nieuwland R, Berckmans RJ, McGregor S, et al.: Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95:930-935
49. EHN Working Party on Definitions of ATEs - Adverse Transfusion Events (ATEs). Available at: http://www.basg.gv.at/uploads/media/110207_EHN_Adverse_Transfusion_Events.pdf (last accessed 20 April 2008)
50. SHOT Annual Reports and Summaries 2011/2012. Available at: http://www.shotuk.org/shot-reports/shot-annual-report-summary-2011/ (Last accessed 20 May 2014)
51. Looney MR, Gropper MA, Matthay MA: Transfusion-related acute lung-injury: review. Chest 2004; 126:249-258
52. Rosiek A, Tomaszewska A, Lachert E, et al.: Blood transfusion service in Poland in 2012. J Transfus Med 2013; 6:119-132
53. Vlaar AP, Hofstra JJ, Determann RM, et al.: The incidence, risk factor, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011; 117:4218-4225
54. Belizaire RM, Prakash PS, Richter JR, et al.: Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. J Am Coll Surg 2012; 214:648-655
55. Tung JP, Fraser JF, Nataatmadja M, et al.: Age of blood and recipient factor determine the severity of transfusion-related acute lung injury (TRALI). Crit Care 2012; 16:1-19
56. Babaev A, Pozzi F, Hare G, et al.: Storage of red cells and transfusion-related acute lung injury. J Anesth Crit Care Open Access 2014; 1:00002
57. Middelburg RA, Borkent-Raven BA, Jansen M, et al.: Storage time of blood products and transfusion-related acute lung injury. Transfusion 2012; 52:658-667
58. Vlaar AP, Binnekade JM, Prins D, et al.: Risk factors and outcome of transfusion-related acute lung injury in critically ill: a nested case-control study. Crit Care Med 2010; 38:771-778
59. Looney MR, Roubinian N, Gajic O, et al.: Prospective study on the clinical course and outcomes in transfusion-related acute lung injury. Crit Care Med 2014; 42:1676-1687
60. Bierling P, Bux J, Curtis B, et al.: Recommendations of the ISBT Working Party on Granulocyte Immuology for leukocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009; 96:266-269
61. Chapman CE, Stainsby D, Jones H, et al.: Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49:440-452
62. Funk MB, Guenay S, Lohmann A, et al.: Benefit of TRALI Risk Reducing Measures-German Haemovigilance Data. Vox Sang 2011; 101(Suppl. 1):321
63. Middelburg RA, van Stein D, Z˙upańska B, et al.: Female donors and transfusion-related acute lung injury. A case-referent study from the International TRALI Unisex Research Group. Transfusion 2010; 50:2447-2454